45 related articles for article (PubMed ID: 2692588)
1. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
Storebø OJ; Storm MRO; Pereira Ribeiro J; Skoog M; Groth C; Callesen HE; Schaug JP; Darling Rasmussen P; Huus CL; Zwi M; Kirubakaran R; Simonsen E; Gluud C
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD009885. PubMed ID: 36971690
[TBL] [Abstract][Full Text] [Related]
2. DCC-related developmental effects of abused- versus therapeutic-like amphetamine doses in adolescence.
Cuesta S; Restrepo-Lozano JM; Popescu C; He S; Reynolds LM; Israel S; Hernandez G; Rais R; Slusher BS; Flores C
Addict Biol; 2020 Jul; 25(4):e12791. PubMed ID: 31192517
[TBL] [Abstract][Full Text] [Related]
3. The clinical utility of the continuous performance test and objective measures of activity for diagnosing and monitoring ADHD in children: a systematic review.
Hall CL; Valentine AZ; Groom MJ; Walker GM; Sayal K; Daley D; Hollis C
Eur Child Adolesc Psychiatry; 2016 Jul; 25(7):677-99. PubMed ID: 26620873
[TBL] [Abstract][Full Text] [Related]
4. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
Storebø OJ; Ramstad E; Krogh HB; Nilausen TD; Skoog M; Holmskov M; Rosendal S; Groth C; Magnusson FL; Moreira-Maia CR; Gillies D; Buch Rasmussen K; Gauci D; Zwi M; Kirubakaran R; Forsbøl B; Simonsen E; Gluud C
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009885. PubMed ID: 26599576
[TBL] [Abstract][Full Text] [Related]
5. Clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials.
Ramtvedt BE; Røinås E; Aabech HS; Sundet KS
J Child Adolesc Psychopharmacol; 2013 Nov; 23(9):597-604. PubMed ID: 23659360
[TBL] [Abstract][Full Text] [Related]
6. Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: complementary treatment options.
Hodgkins P; Shaw M; Coghill D; Hechtman L
Eur Child Adolesc Psychiatry; 2012 Sep; 21(9):477-92. PubMed ID: 22763750
[TBL] [Abstract][Full Text] [Related]
7. An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults.
Wilens TE; Morrison NR; Prince J
Expert Rev Neurother; 2011 Oct; 11(10):1443-65. PubMed ID: 21955201
[TBL] [Abstract][Full Text] [Related]
8. Animal models to guide clinical drug development in ADHD: lost in translation?
Wickens JR; Hyland BI; Tripp G
Br J Pharmacol; 2011 Oct; 164(4):1107-28. PubMed ID: 21480864
[TBL] [Abstract][Full Text] [Related]
9. Cross-species assessments of motor and exploratory behavior related to bipolar disorder.
Henry BL; Minassian A; Young JW; Paulus MP; Geyer MA; Perry W
Neurosci Biobehav Rev; 2010 Jul; 34(8):1296-306. PubMed ID: 20398694
[TBL] [Abstract][Full Text] [Related]
10. Abuse of amphetamines and structural abnormalities in the brain.
Berman S; O'Neill J; Fears S; Bartzokis G; London ED
Ann N Y Acad Sci; 2008 Oct; 1141():195-220. PubMed ID: 18991959
[TBL] [Abstract][Full Text] [Related]
11. Psychostimulant treatment and the developing cortex in attention deficit hyperactivity disorder.
Shaw P; Sharp WS; Morrison M; Eckstrand K; Greenstein DK; Clasen LS; Evans AC; Rapoport JL
Am J Psychiatry; 2009 Jan; 166(1):58-63. PubMed ID: 18794206
[TBL] [Abstract][Full Text] [Related]
12. Potential adverse effects of amphetamine treatment on brain and behavior: a review.
Berman SM; Kuczenski R; McCracken JT; London ED
Mol Psychiatry; 2009 Feb; 14(2):123-42. PubMed ID: 18698321
[TBL] [Abstract][Full Text] [Related]
13. Methylphenidate and its isomers: their role in the treatment of attention-deficit hyperactivity disorder using a transdermal delivery system.
Heal DJ; Pierce DM
CNS Drugs; 2006; 20(9):713-38. PubMed ID: 16953648
[TBL] [Abstract][Full Text] [Related]
14. Drug therapy for adults with attention-deficit hyperactivity disorder.
Wilens TE
Drugs; 2003; 63(22):2395-411. PubMed ID: 14609347
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and clinical effectiveness of methylphenidate.
Kimko HC; Cross JT; Abernethy DR
Clin Pharmacokinet; 1999 Dec; 37(6):457-70. PubMed ID: 10628897
[TBL] [Abstract][Full Text] [Related]
16. Drug treatment for hyperactive children. Therapeutic guidelines.
Elia J
Drugs; 1993 Nov; 46(5):863-71. PubMed ID: 7507036
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of methylphenidate and dextroamphetamine on the motor activity level of hyperactive children.
Borcherding BG; Keysor CS; Cooper TB; Rapoport JL
Neuropsychopharmacology; 1989 Dec; 2(4):255-63. PubMed ID: 2692588
[TBL] [Abstract][Full Text] [Related]
18. Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction: controlled comparison by placebo washout design with Bayes' analysis.
Arnold LE; Christopher J; Huestis R; Smeltzer DJ
Arch Gen Psychiatry; 1978 Apr; 35(4):463-73. PubMed ID: 365123
[TBL] [Abstract][Full Text] [Related]
19. The effects of methylphenidate on the mother-child interactions of hyperactive children.
Barkley RA; Cunningham CE
Arch Gen Psychiatry; 1979 Feb; 36(2):201-8. PubMed ID: 369470
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
